Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Free Dating
Ñompany Maksim-LLC. Ýëåêòðîïðèâîäû. Made and sell.
Popular Articles

New "microcapsules" Put More Medication Into The Bloodstream To Treat Disease
Scientists are reporting a potential solution to a problem that limits the human body"s ability to absorb and use medications for heart disease, Type-2 diabetes, cancer and other conditions. It is a "nano-hybrid microcapsule" that enables the stomach to absorb more of these so-called "poorly-soluble" medicines. Their study is scheduled for the June 1 issue of ACS" Molecular Pharmaceutics, a bi-monthly journal.
new payday loan lenders
Obama Names NYC Health Commissioner Frieden Next CDC Director
President Obama on Friday named New York City Health Commissioner Thomas Frieden as the new director of the Centers for Disease Control and Prevention, the New York Times reports. It has long been expected that Obama would select Frieden, an infectious disease specialist who is "widely admired" in the public health arena, according to the Times. In his seven years as health commissioner of New York City, Frieden pushed to establish HIV testing as a part of routine medical exams and defended a condom-distribution program that hands out more than 35 million condoms annually. Frieden is expected to take office in June and does not require Senate confirmation for the position. He will replace Richard Besser, the current acting director of CDC, who will return to his position as head of CDC"s coordinating office for terrorism preparedness and emergency response.The Times reports that Frieden will "inherit a host of immediate and long-term problems" at CDC, including organizational issues, low morale and the Obama administration"s health care reform agenda. "Health care reform also needs to be on his plate," Jeffrey Koplan, who served as CDC director from 1998 to 2002, said, adding, "There is a huge opportunity there to improve public health, and it"s one in which any CDC director will want to be a player." Several health care advocates praised the appointment, according to the Times. Dennis deLeon, president of the Latino Commission on AIDS in New York City said that Frieden is "willing to challenge the status quo in an effort to make a difference." Jeffrey Levi, executive director of the not-for-profit Trust for America"s Health, said Frieden is a "transformational leader" who "can take public health to a new place" (Harris/Hartocollis, New York Times, 5/15).
News of the day
Personal Exposure Monitors Show Pharmacy Workers Inhale Drugs When Using Air Pressure-Activated Dispensing Machines
AlburtyLab released a report on its comprehensive evaluation of health risks for workers in pharmacies using air pressure-activated drug dispensing machines. The study tested pharmacy workers wearing personal exposure monitors (PEMs) while using the two leading types of air pressure-activated dispensing technologies - the McKesson/Parata Max and the McKesson/Parata RDS. This is the third major study conducted by AlburtyLab examining the issues relating to pharmacy worker exposure.
Oncology

SCRIP's 'Best-In-Class' Reporting Recognised By Industry - Journalist Malani Guha Wins Advances In Renal Cancer Journalists' Award

Journalist, Malini Guha, has won the prestigious new Advances in Renal Cancer Journalists" Award - Europe for her article "New Advances Deliver Fresh Hope in Kidney Cancer" - which was published in Scrip World Pharmaceutical News on February 13th 2009. The award was presented by the esteemed Association of German Medical Journalists (VDMJ) at this month"s Fourth European International Kidney Cancer Symposium in Berlin. In her article, Malini Guha - Science Editor at Scrip - provides a concise and informative review of the current options and prospects of success in the treatment of renal cell carcinoma. "It is a great honour to be the first-ever recipient of this award," says Malini. "My article focused on the significant progress made in the treatment of kidney cancer in recent years and also examined the outlook for other approaches which may further improve patient outcomes." The jury - comprising Professor Peter Mulders, Department of Urology, University Medical Center St Radboud, Nijmwegan in the Netherlands; Dr Bernard Escudier, Institut Gustave Roussy, Villejuif in France; and Torsten Hoffman, President of the VdMJ, Stuttgart in Germany - evaluated submissions from print media and were highly complimentary of Malini"s work. The panel said: "The article comes across as both scientifically accurate and clearly comprehensible, aiming to give interested readers the necessary information on the latest research into treatment in this indication in a manner that is comprehensive and yet not overtaxing. "Guha"s writing adheres to the guiding principle of medical journalism: "do not stir up anxiety and do not raise unreasonable hopes." The article is a testament to the detailed investigative work conducted by Malini Guha herself at research centers, hospitals and amongst specialist oncologists. This, too, is a mark of good journalistic practice. Furthermore, the journalist"s own personal interest in the subject matter also contributes to the success of this commendable publication." "We are delighted that Malini"s work has been recognised so publicly in the form of this highly prestigious award," says Phil Jarvis, Publisher of Scrip World Pharmaceutical News. "It is a testament to her talent, hard work and vast knowledge of the subject matter and we are extremely proud to have published her work in Scrip." The Advances in Renal Cancer Journalists" Award - Europe was sponsored by Bayer Healthcare AG and was presented to Malini Guha on May 8th, 2009. Scrip World Pharmaceutical News


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009